B-RAF drives regenerative axon growth in the optic nerve in vivo

B-RAF 驱动体内视神经再生轴突生长

基本信息

  • 批准号:
    8658099
  • 负责人:
  • 金额:
    $ 44.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-05-01 至 2017-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Injured axons in the mature central nervous system (CNS), including the optic nerve, cannot regenerate spontaneously. This inability to regenerate causes permanent disability after CNS injuries. A better understanding of the impediments to axon regeneration, and novel approaches towards overcoming them, are necessary for the development of new drugs and procedures that may improve the fate of patients with nervous system injury in the future. Our goal is to enable CNS axon regeneration by elevating intrinsic growth signaling. The RAF kinase is known to drive fast axon growth in embryonic sensory neurons; we therefore will now activate this kinase in the retina. Our first aim is to promote regeneration in the injured optic nerve using a conditional B-RAF gain-of-function mouse model. We will then test the roles of signaling molecules downstream of RAF signaling - the MEKs, ERKs and RNDs - for their contributions to B-RAF-driven retinal axon regeneration (Aim 2). Next, we plan to combine activation of B-RAF with activation of PI3-kinase signaling (using a knock-out of the PI3-kinase antagonist PTEN) to see whether this combination will further boost regenerative optic nerve axon growth in vivo (Aim 3). If we can observe regeneration into any of the optic tract nuclei, we will test the mice for any recovery of visual function; such functional recovery being the ultimate goal of all axon regeneration studies. The proposed study will define the roles of RAF signaling and its downstream effectors in the context of optic nerve regeneration, laying groundwork for translational research and for the identification of novel drug targets.
描述(由申请人提供):成熟中枢神经系统(CNS)损伤的轴突,包括视神经,不能自发再生。这种再生能力导致中枢神经系统损伤后的永久性残疾。更好地了解轴突再生的障碍,以及克服这些障碍的新方法,对于未来可能改善神经系统损伤患者命运的新药物和新程序的开发是必要的。我们的目标是通过提升内在生长信号来实现中枢神经系统轴突的再生。已知RAF激酶驱动胚胎感觉神经元的快速轴突生长;因此我们现在要激活视网膜上的激酶。我们的第一个目标是使用条件B-RAF功能获得小鼠模型促进受损视神经的再生。然后,我们将测试RAF信号下游的信号分子- MEKs, ERKs和rnd -在b -RAF驱动的视网膜轴突再生中的作用(Aim 2)。接下来,我们计划将B-RAF的激活与pi3激酶信号的激活(使用敲除pi3激酶拮抗剂PTEN)结合起来,看看这种组合是否会进一步促进再生视神经轴突的体内生长(目的3)。如果我们能观察到再生进入任何视神经束核,我们将测试小鼠的视觉功能是否恢复;这种功能恢复是所有轴突再生研究的最终目标。本研究将明确RAF信号及其下游效应物在视神经再生中的作用,为转化研究和新药鉴定奠定基础

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jian Zhong其他文献

Jian Zhong的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jian Zhong', 18)}}的其他基金

Engaging neuron-intrinsic signaling for axon growth after spinal cord injury
脊髓损伤后轴突生长的神经元内在信号传导
  • 批准号:
    10213845
  • 财政年份:
    2017
  • 资助金额:
    $ 44.35万
  • 项目类别:
Engaging neuron-intrinsic signaling for axon growth after spinal cord injury
脊髓损伤后轴突生长的神经元内在信号传导
  • 批准号:
    9383972
  • 财政年份:
    2017
  • 资助金额:
    $ 44.35万
  • 项目类别:
B-RAF drives regenerative axon growth in the optic nerve in vivo
B-RAF 驱动体内视神经再生轴突生长
  • 批准号:
    8520804
  • 财政年份:
    2012
  • 资助金额:
    $ 44.35万
  • 项目类别:
B-RAF drives regenerative axon growth in the optic nerve in vivo
B-RAF 驱动体内视神经再生轴突生长
  • 批准号:
    8843867
  • 财政年份:
    2012
  • 资助金额:
    $ 44.35万
  • 项目类别:
B-RAF drives regenerative axon growth in the optic nerve in vivo
B-RAF 驱动体内视神经再生轴突生长
  • 批准号:
    8461561
  • 财政年份:
    2012
  • 资助金额:
    $ 44.35万
  • 项目类别:
B-RAF drives regenerative axon growth in the optic nerve in vivo
B-RAF 驱动体内视神经再生轴突生长
  • 批准号:
    8275081
  • 财政年份:
    2012
  • 资助金额:
    $ 44.35万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 44.35万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.35万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 44.35万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.35万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 44.35万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 44.35万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.35万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 44.35万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 44.35万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.35万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了